56. ベーチェット病 Behcet disease Clinical trials / Disease details

臨床試験数 : 81 / 薬物数 : 107 - (DrugBank : 30) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02756650 (ClinicalTrials.gov)	June 23, 2016	31/3/2016	1 Year of Treatment With Canakinumabin Behçet's Disease Patients With Neurologic or Vascular Involve ...	An Open Label, Exploratory Study to Establish the Efficacy and Safety of 1 Year CanakinumabTreatment ...	Behcet Disease	Drug: Canakinumab	Novartis Pharmaceuticals	NULL	Completed	18 Years	60 Years	All	8	Phase 2	Turkey
2	EUCTR2010-024152-29-DE (EUCTR)	02/09/2011	21/06/2011	An open-label study to evaluate efficacy and tolerability of Canakinumabin patients with Behçet Dise ...	Canakinumab for Behçet`s Disease Resistant to Standard Treatment(CanBeDisT) - CanBeDisT	Behçet`s Disease MedDRA version: 14.0;Level: PT;Classification code 10004213;Term: Behcet's syndrome ...	Trade Name: Ilaris Product Name: Ilaris INN or Proposed INN: CANAKINUMAB	University Hospital of Tübingen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10		Germany

First Previous1Next Last